Publications

Search Publications
Export 710 results:
Author [ Title(Desc)] Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
Chen H, Levo M, Barinov L, Fujioka M, Jaynes JB, Gregor T. Dynamic interplay between enhancer-promoter topology and gene activity. Nat Genet. 2018 ;50(9):1296-1303.
Coen P, Clemens J, Weinstein AJ, Pacheco DA, Deng Y, Murthy M. Dynamic sensory cues shape song structure in Drosophila. Nature. 2014 ;507(7491):233-7.
Coen P, Clemens J, Weinstein AJ, Pacheco DA, Deng Y, Murthy M. Dynamic sensory cues shape song structure in Drosophila. Nature. 2014 ;507(7491):233-7.
E
Cristea IM, Dorrestein PC, Eisen JA, Gilbert JA, Huber JA, Jansson JK, et al. Early-Career Scientists Shaping the World. mSystems. 2019 ;4(3).
Cristea IM, Lilley KS. Editorial overview: Untangling proteome organization in space and time. Curr Opin Chem Biol. 2019 ;48:A1-A4.
Gao S, Valinsky WC, On NCam, Houlihan PR, Qu Q, Liu L, et al. Employing NaChBac for cryo-EM analysis of toxin action on voltage-gated Na channels in nanodisc. Proc Natl Acad Sci U S A. 2020 ;117(25):14187-14193.
Berg RA, Reeder RW, Meert KL, Yates AR, Berger JT, Newth CJ, et al. End-tidal carbon dioxide during pediatric in-hospital cardiopulmonary resuscitation. Resuscitation. 2018 ;133:173-179.
Berg RA, Reeder RW, Meert KL, Yates AR, Berger JT, Newth CJ, et al. End-tidal carbon dioxide during pediatric in-hospital cardiopulmonary resuscitation. Resuscitation. 2018 ;133:173-179.
Song K, Cai X, Dong Y, Wu H, Wei Y, Shankavaram U, et al. Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development. J Clin Invest. 2020 ;.
Song K, Cai X, Dong Y, Wu H, Wei Y, Shankavaram U, et al. Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development. J Clin Invest. 2020 ;.
Song K, Cai X, Dong Y, Wu H, Wei Y, Shankavaram U, et al. Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development. J Clin Invest. 2020 ;.
Song K, Cai X, Dong Y, Wu H, Wei Y, Shankavaram U, et al. Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development. J Clin Invest. 2020 ;.
Rosenzweig ESFreeman, Xu B, Cuellar LKuhn, Martinez-Sanchez A, Schaffer M, Strauss M, et al. The Eukaryotic CO-Concentrating Organelle Is Liquid-like and Exhibits Dynamic Reorganization. Cell. 2017 ;171(1):148-162.e19.
Rosenzweig ESFreeman, Xu B, Cuellar LKuhn, Martinez-Sanchez A, Schaffer M, Strauss M, et al. The Eukaryotic CO-Concentrating Organelle Is Liquid-like and Exhibits Dynamic Reorganization. Cell. 2017 ;171(1):148-162.e19.
Wühr M, Chen Y, Dumont S, Groen AC, Needleman DJ, Salic A, et al.. Evidence for an upper limit to mitotic spindle length. Curr Biol. 2008 ;18(16):1256-61.
Semmelhack MF, Campagna SR, Federle MJ, Bassler BL. An expeditious synthesis of DPD and boron binding studies. Org Lett. 2005 ;7(4):569-72.
Stern DL, Clemens J, Coen P, Calhoun AJ, Hogenesch JB, Arthur BJ, et al. Experimental and statistical reevaluation provides no evidence for courtship song rhythms. Proc Natl Acad Sci U S A. 2017 ;114(37):9978-9983.
Stern DL, Clemens J, Coen P, Calhoun AJ, Hogenesch JB, Arthur BJ, et al. Experimental and statistical reevaluation provides no evidence for courtship song rhythms. Proc Natl Acad Sci U S A. 2017 ;114(37):9978-9983.
Stern DL, Clemens J, Coen P, Calhoun AJ, Hogenesch JB, Arthur BJ, et al. Experimental and statistical reevaluation provides no evidence for courtship song rhythms. Proc Natl Acad Sci U S A. 2017 ;114(37):9978-9983.
Satoh T, Kang Y-K, Chao Y, Ryu M-H, Kato K, Chung HCheol, et al. Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer. Gastric Cancer. 2020 ;23(1):143-153.
Satoh T, Kang Y-K, Chao Y, Ryu M-H, Kato K, Chung HCheol, et al. Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer. Gastric Cancer. 2020 ;23(1):143-153.
Satoh T, Kang Y-K, Chao Y, Ryu M-H, Kato K, Chung HCheol, et al. Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer. Gastric Cancer. 2020 ;23(1):143-153.
Satoh T, Kang Y-K, Chao Y, Ryu M-H, Kato K, Chung HCheol, et al. Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer. Gastric Cancer. 2020 ;23(1):143-153.
Satoh T, Kang Y-K, Chao Y, Ryu M-H, Kato K, Chung HCheol, et al. Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer. Gastric Cancer. 2020 ;23(1):143-153.
Satoh T, Kang Y-K, Chao Y, Ryu M-H, Kato K, Chung HCheol, et al. Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer. Gastric Cancer. 2020 ;23(1):143-153.